The Weekly Roundup

October 27, 2017

While topics at the NCPA 2017 annual conference ranged broadly, one of the most talked-about themes inside and outside the halls of learning was definitely (and unsurprisingly) DIR fees(If you missed the event, this will give you a taste that might sway you to attend next year). Let’s face it: pharmacists are beside themselves. Earlier this year, DIR fees were called “legalized theft” in this piece on their connection to Star Ratings. Pharmacies first need to know how the fees are calculated: on a percentage- versus a per-prescription-basis. Then, if there are clinical or operational data that can change the rate (Star Ratings criteria like adherence rates or contract criteria like GDR), pharmacies can impact the fees ultimately charged. Meanwhile, tools like the DIR fee estimator are creating at least more predictability for pharmacies. Ultimately, though, relief may be in legislation. NCPA has made a strong push for the enactment of S. 413 / H.R. 1038, which would prohibit retroactive DIR fees, and many states are pursuing their own versions of transparency bills. Stay tuned.

Here are a few other stories that might be of interest:

Continue reading →

The Weekly Roundup

July 08, 2016 | Pamela Youngberg Dickson

We hope you’ve had a safe and enjoyable week celebrating the July 4th holiday with family and friends. Did you restock the sunscreen? Drug Store News has issued a much-needed reminder about the importance of sunscreen. But it’s not just our skin that needs protection from the sun’s rays. Check out these tips for protecting medication from heat and sun from Pharmacy Times, and don’t forget to remind your patients that some medications increase their risk for sun sensitivity. Need more help educating your patients on sun safety? Print out our Smart-Take on skin cancer and distribute it at your store.

Here are few stories we came across this week that you might find interesting:

Continue reading →